GC-MS and GC-IRD studies on dimethoxyamphetamines (DMA): Regioisomers related to 2,5-DMA

Forensic Science International

Volumn 192, Issue 1-3, 2009, Pages 115-125

  Maher, Hadir M ^a   Awad, Tamer ^b,c   DeRuiter, Jack ^c   Clark, C Randall ^c  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b Suez Canal University   (Egypt)

^c AUBURN UNIVERSITY   (United States)

Author keywords

Dimethoxyamphetamines (DMA); GC IRD; GC MS; Perfluoroacylation; Regioisomers

Indexed keywords

2,5 DIMETHOXYAMPHETAMINE; AMINE; AMPHETAMINE DERIVATIVE; DIMETHOXYAMPHETAMINE DERIVATIVE; NITROGEN; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; GAS CHROMATOGRAPHY; INFRARED SPECTROPHOTOMETRY; ISOMER; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL;

EID: 70349508948     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2009.08.010     Document Type: Article

References (23)

1. Kanai K., Takekawa K., Kumamoto T., Ishikawa T., and Ohmori T. Simultaneous analysis of six phenethylamine-type designer drugs by TLC, LC-MS, and GC-MS. Forensic Toxicol. 26 (2008) 6-12
2. Boatto G., Nieddu M., Carta A., Pau A., Palomba M., Asproni B., and Cerr R. Determination of amphetamine-derived designer drugs in human urine by SPE extraction and capillary electrophoresis with mass spectrometry detection. J. Chromatogr. B 814 (2005) 93-98
3. Christophersen A.S. Amphetamine designer drugs-an overview and epidemiology. Toxicol. Lett. (2000) 112-113
4. Neuvonen K., Neuvonen H., and Fulop F. Effect of 4-substitution on psychotomimetic activity of 2,5-dimethoxy amphetamines as studied by means of different substituent parameter scales. Bioorg. Med. Chem. Lett. 16 (2006) 3495-3498
5. Ewald A.H., Ehlers D., and Maurer H.H. Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry. Anal. Bioanal. Chem. 390 (2008) 1837-1842
6. Drug Enforcement Administration-Office of Forensic Sciences. Microgram 40 (2007) 93
7. Frison G., Tedeschi L., Favretto D., Reheman A., and Ferrara S.D. Gas chromatography/mass spectrometry determination of amphetamine-related drugs and ephedrines in plasma, urine and hair samples after derivatization with 2,2,2-trichloroethyl chloroformate. Rapid Commun. Mass Spectrom. 19 (2005) 919-927
8. Hidvegi E., Fabian P., Hideg Z., and Somogyi G. GC-MS determination of amphetamines in serum using on-line trifluoroacetylation. Forensic Sci. Int. 16 (2006) 119-123
9. Theobald D.S., Putz E., Schneider H.H., and Maurer. New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques. J. Mass Spectrom. 41 (2006) 872-886
10. Ewald A.H., Puetz M., Maurer H.H., and Hans H. Designer drug 2,5-dimethoxy-4-methyl-amphetamine (DOM, STP): involvement of the cytochrome P450 isoenzymes in formation of its main metabolite and detection of the latter in rat urine as proof of a drug intake using gas chromatography-mass spectrometry. J. Chromatogr. B 862 (2008) 252-256
11. Soares M.E., Carvalho M., Carmo H., Remiao F., Carvalho F., and Bastos M.L. Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis. Biomed. Chromatogr. 18 (2004) 125-131
12. Nieddu M., Boatto G., Carta A., Sanna A., and Pisano M. Simultaneous determination of ten amphetamine designer drugs in human whole blood by capillary electrophoresis with diode array detection. Biomed. Chromatogr. 19 (2005) 737-742
13. Cody J.T., John T., and Schwarzhoff R. Fluorescence polarization immunoassay detection of amphetamine, methamphetamine, and illicit amphetamine analogs. J. Anal. Toxicol. 17 (1993) 26-30
14. Praisler M., Dirinck I., Van Bocxlaer J., De Leenheer A., and Massart D.L. Pattern recognition techniques screening for drugs of abuse with gas chromatography-Fourier transform infrared spectroscopy. Talanta 53 (2000) 177-193
15. Awad T., Clark C.R., and DeRuiter J. GC-MS analysis of acylated derivatives of the side chain regioisomers of 4-methoxy-3-methyl phenethylamines related to methylenedioxymethamphetamine. J. Chromatogr. Sci. 45 (2007) 477-485
16. Awad T., DeRuiter J., and Clark C.R. Gas chromatography-mass spectrometry analysis of regioisomeric ring substituted methoxy methyl phenylacetones. J. Chromatogr. Sci. 45 (2007) 458-465
17. Awad T., DeRuiter J., and Clark C.R. GC-MS analysis of acylated derivatives of a series of side chain regioisomers of 2-methoxy-4-methyl-phenethylamines. J. Chromatogr. Sci. 46 (2008) 375-380
18. Belal T., Awad T., DeRuiter J., and Clark C.R. GC-MS studies on acylated derivatives of 3-methoxy-4-methyl- and 4-methoxy-3-methyl-phenethylamines: regioisomers related to 3,4-MDMA. Forensic Sci. Int. 178 (2008) 61-82
19. Gosav S., Praisler M., Van Bocxlaer J., De Leenheer A.P., and Massart D.L. Class identity assignment for amphetamines using neural networks and GC-FTIR data. Spectrochim. Acta A 64 (2006) 1110-1117
20. Belal T., Awad T., DeRuiter J., Kramer K., and Clark C.R. GC-IRD methods for the identification of isomeric ethoxyphenethylamines and methoxymethcathinones. Forensic Sci. Int. 184 (2009) 54-63
21. Belal T., Awad T., DeRuiter J., Kramer K., and Clark C.R. Comparison of GC-MS and GC-IRD methods for the differentiation of methamphetamine and regioisomeric substances. Forensic Sci. Int. 185 (2009) 67-77
22. Maher H.M., Awad T., and Clark C.R. Differentiation of the regioisomeric 2, 3 and 4-trifluoromethylphenylpiperazines (TFMPP) by GC-IRD and GC-MS. Forensic Sci. Int. 188 (2009) 31-39
23. DeRuiter J., Holston P., Clark C.R., Noggle F.T., and Taylor F. Liquid chromatographic and mass spectral methods of identification for regioisomeric dimethoxyamphetamines and brominated dimethoxyamphetamines. J. Chromatogr. Sci. 36 (1998) 73-79